Incidence of Moxifloxacin Resistance in Clinical Mycobacterium tuberculosis Isolates in Houston, Texas
- 1 August 2011
- journal article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 49 (8) , 2942-2945
Abstract
Comprehensive data on the prevalence of quinolone resistance in Mycobacterium tuberculosis clinical isolates in the United States are scarce. By use of a systematic population-based approach, M. tuberculosis strains from tuberculosis (TB) cases were collected in Harris County, TX, in 2007 to 2008. The susceptibilities of M. tuberculosis isolates to moxifloxacin and ofloxacin were determined by the agar proportion indirect susceptibility method. Spoligotyping and 12-locus mycobacterial interspersed repetitive unit (MIRU12)-based genotyping of M. tuberculosis isolates were performed, and the gyrA , gyrB , Rv2686c, Rv2687c, and Rv2688c genes in quinolone-resistant and year-of-diagnosis-matched M. tuberculosis isolates were sequenced. Susceptibility testing was performed on 557 M. tuberculosis isolates, of which 10 (1.8%) were resistant to moxifloxacin. There was 100% concordance between ofloxacin and moxifloxacin susceptibilities. A quinolone was prescribed to at least 5 (50%) patients in the period preceding TB diagnosis. Multidrug-resistant TB (MDR-TB) was significantly associated with quinolone resistance ( P = 0.01). Mutations in the quinolone resistance-determining region of gyrA were found for 50% of the resistant isolates. No other presumptive quinolone resistance-associated mutations were identified. We conclude that the incidence of moxifloxacin-resistant TB is low in Harris County and is associated with MDR-TB. Previous exposure to quinolones is common among patients with moxifloxacin resistance and warrants more careful evaluation.Keywords
This publication has 35 references indexed in Scilit:
- Drug Resistant Mycobacterium tuberculosis of the Beijing Genotype Does Not Spread in SwedenPLOS ONE, 2010
- Beijing Genotype of Mycobacterium tuberculosis Is Significantly Associated with High-Level Fluoroquinolone Resistance in VietnamAntimicrobial Agents and Chemotherapy, 2009
- Fluoroquinolone Resistance in Mycobacterium tuberculosis and Mutations in gyrA and gyrBAntimicrobial Agents and Chemotherapy, 2009
- Newer fluoroquinolones for treating respiratory infection: do they mask tuberculosis?European Respiratory Journal, 2009
- Fluoroquinolone Resistance in Mycobacterium tuberculosis : The Effect of Duration and Timing of Fluoroquinolone ExposureAmerican Journal of Respiratory and Critical Care Medicine, 2009
- Clusters of Multidrug-ResistantMycobacterium tuberculosisCases, EuropeEmerging Infectious Diseases, 2009
- Over the Counter Availability of Antituberculosis Drugs in Tbilisi, Georgia in the Setting of a High Prevalence of MDR-TBInterdisciplinary Perspectives on Infectious Diseases, 2009
- Moxifloxacin versus ethambutol in the initial treatment of tuberculosis: a double-blind, randomised, controlled phase II trialThe Lancet, 2009
- Comprehensive Treatment of Extensively Drug-Resistant TuberculosisNew England Journal of Medicine, 2008
- Molecular Characterization of Ofloxacin-ResistantMycobacterium tuberculosisStrains from RussiaAntimicrobial Agents and Chemotherapy, 2008